SCHEDULE: Valiant Capital Discloses 5.1% Stake in Core Scientific

Valiant Capital Management and its affiliates have reported a 5.1% beneficial ownership stake in Core Scientific, Inc., holding over 16.2 million shares.

Summary

• Valiant Capital Management, L.P., Valiant Capital Management, LLC, and Christopher R. Hansen collectively reported beneficial ownership of 16,212,903 shares of Core Scientific, Inc. Common Stock.
• This ownership represents 5.1% of Core Scientific's outstanding Common Stock.
• The percentage is calculated based on 315,332,655 shares outstanding as of February 26, 2026, as reported in Core Scientific's Form 10-K for the fiscal year ended December 31, 2025.
• The reporting persons have shared voting power and shared dispositive power over all 16,212,903 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Core Scientific, Inc.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it indicates a significant institutional investor has taken a substantial stake, suggesting confidence in Core Scientific without implying any immediate operational changes or financial performance.

Positives

• A significant institutional investor, Valiant Capital Management, has disclosed a 5.1% stake in Core Scientific, which can be interpreted as a vote of confidence in the company's prospects.
• The acquisition of shares was stated to be in the ordinary course of business, suggesting a long-term investment strategy rather than an activist play.

Industry Context

StockSavvy.ai notes that a significant stake by an investment firm like Valiant Capital Management in Core Scientific, a major player in the Bitcoin mining sector, could signal growing institutional interest or confidence in the long-term viability and growth potential of the cryptocurrency mining industry. This type of disclosure often attracts attention from other investors looking for signals of smart money allocation within the sector.

Stakeholder Impact

• Shareholders may view the disclosure of a new 5.1% institutional holder as a positive signal, potentially increasing confidence in the stock and attracting further investment interest.
• The company's management might see this as validation of their strategy and operations, potentially leading to increased engagement with the new significant shareholder.

Key Dates

Recommendation

A seasoned investor would likely view this Schedule 13G filing as a notable data point indicating institutional interest in Core Scientific. While it doesn't provide new fundamental information about the company's operations or financial performance, the acquisition of a significant stake by Valiant Capital Management suggests a belief in the company's long-term value. This information alone is not sufficient to warrant a 'buy' or 'sell' recommendation, but it reinforces a 'hold' position for existing investors and encourages further due diligence for potential investors, as it signals 'smart money' involvement.

Keywords

Core Scientific, Valiant Capital Management, Beneficial Ownership, Institutional Investment, SEC Filing, Common Stock, Bitcoin Mining, Crypto Mining